menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A New Use for Botulinum Toxin — Chronic Migraines

A New Use for Botulinum Toxin — Chronic Migraines
RestartResume
14 million Americans suffer migraine headaches everyday. Many go untreated and many who are treated continue to have headaches. An old drug may off...
  • Overview

    14 million Americans suffer migraine headaches everyday. Many go untreated and many who are treated continue to have headaches. An old drug may offer a new way to treat migraines, with the FDA approval of botulinum toxin injections for severe chronic migraine. Dr. David Simpson, professor of neurology at Mount Sinai School of Medicine in New York City and director of the clinical neurophysiology lab at Mount Sinai Hospital, joins host Dr. Anthony Alessi to discuss what patients qualify for this treatment, problems and risks associated with taking the injections, and the controversial results of the clinical trials for this treatment, including the PREEMPT 1 and 2 trials.

    Produced in cooperation with:

    AAN Logo

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.